Abbott(ABT)
Search documents
10 Best 52-Week Low Blue Chip Stocks to Buy Right Now
Insider Monkey· 2026-02-07 09:26
In this article, we will look at the 10 Best 52-Week Low Blue Chip Stocks to Buy Right Now.The S&P 500 has performed exceedingly well over the past two years, powering to all-time highs amid easing inflation and the artificial intelligence boom. Despite the 24% and 14% gains over the past two years, respectively, not every company has had a great time over the same period.While some stocks are flirting with record highs after blockbuster gains, others have pulled back significantly and are trading close to ...
Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro
PRWEB· 2026-02-06 21:31
"Innovation in diagnostics only creates value when it reaches the people who use it every day—clinicians, laboratories, and patients." Claudia Marcela Riaño Caro Post this The program combined data-driven market analysis, localized commercial strategy, and structured clinical and technical education to ensure alignment between diagnostic solutions and local healthcare system needs. "Expanding diagnostics in emerging markets requires more than technology alone," said Riaño. "It requires trust, education, an ...
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
Prnewswire· 2026-02-06 13:00
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation [Accessibility Statement] Skip Navigation- New data from the FOCALFLEX CE Mark trial demonstrate the safety and efficacy of the TactiFlexâ"¢ Duo Ablation Catheter, Sensor Enabledâ"¢, to significantly reduce AFib episodes for complex cases2- Positive 12-month results from the VOLT-AF IDE Study presented at the AF Symposium and simultaneously published in JACC: Clinical Ele ...
Abbott recalls glucose sensors after seven deaths linked to faulty readings
Reuters· 2026-02-04 15:49
Abbott has recalled certain glucose monitoring sensors after reports linked the devices to seven deaths and 860 serious injuries, the U.S. health regulator said on Wednesday. ...
Do Wall Street Analysts Like Abbott Laboratories Stock?
Yahoo Finance· 2026-02-04 14:37
With a market cap of $189.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of medical products across pharmaceuticals, diagnostics, nutrition, and medical devices. It serves patients worldwide with solutions spanning disease treatment, testing and diagnostics, nutrition, cardiovascular care, diabetes management, and neuromodulation. Shares of the Abbott Park, Illinois-based company have underperformed the broader market ove ...
5 Goldman Sachs Top Stock Picks Have Huge Upside Potential and Pay Dividends
247Wallst· 2026-02-04 13:43
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and ranks 55th on the Fortune 500 list of the largest U.S. ...
Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure
Yahoo Finance· 2026-02-03 14:20
Abbott Laboratories (NYSE:ABT) is included among the Dividend Growth Stocks: 25 Aristocrats. Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure Courtesy of Abbott Labs A Reuters report said Abbott Laboratories (NYSE:ABT) warned that its current-quarter profit would come in below expectations after the company also fell short of Wall Street’s revenue forecasts on January 22. Pressure has been building in Abbott’s pediatric nutrition business, which has struggled in recent q ...
The Best Dividend King to Buy With $150
Yahoo Finance· 2026-02-02 17:05
Shares of Abbott Laboratories (NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away from Abbott given some recent challenges. However, Abbott's stock still remains attractive, especially for dividend-seeking investors. Here is why. Abbott's quarterly update Abbott Laboratories' fourth-quarter top-line growth came up short of expectations. The company's sales were $11.5 billion, up 4.4% compa ...
Abbott: Long-Term Investment Opportunity For Dividend Growth Investors
Seeking Alpha· 2026-02-02 14:30
Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]